Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-01-30 4:31 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.9% | 4,000,000 (New Position) | View |
2024-01-09 4:46 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.5% | 20,817,249 (+251.14%) | View |
2024-01-08 4:15 pm Sale | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,247,914 9.9% | -540,000 (-11.28%) | View |
2024-01-08 4:05 pm Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,787,914 11.2% | 850,000 (+21.59%) | View |
2023-12-08 4:10 pm Purchase | 13D | CAZOO GROUP LTD OCT 2023 CZOO | VIKING GLOBAL INVESTORS LP | 2,142,728 43.8% | 2,142,728 (New Position) | View |
2023-11-22 4:15 pm Unchanged | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.5% | 0 (Unchanged) | View |
2023-11-22 4:15 pm Unchanged | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.7% | 0 (Unchanged) | View |
2023-11-22 4:15 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-11-07 4:10 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-11-02 4:30 pm Purchase | 13G | VIKING THERAPEUTICS INC VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.9% | 5,858,532 (New Position) | View |
2023-10-16 4:30 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.5% | -34,705 (-0.42%) | View |
2023-10-06 4:15 pm Purchase | 13G | FIVE9 INC FIVN | VIKING GLOBAL INVESTORS LP | 3,647,595 5.1% | 3,647,595 (New Position) | View |
2023-09-22 5:24 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-09-21 5:10 pm Purchase | 13G | RAYZEBIO INC RYZB | VIKING GLOBAL INVESTORS LP | 6,642,700 10.9% | 6,642,700 (New Position) | View |
2023-08-24 4:30 pm Purchase | 13G | VALVOLINE INC VVV | VIKING GLOBAL INVESTORS LP | 8,338,456 6% | 8,338,456 (New Position) | View |
2023-07-19 9:52 pm Sale | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.7% | -1,500,000 (-5.63%) | View |
2023-06-26 5:05 pm Sale | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 75,238,700 9.9% | -13,000,000 (-14.73%) | View |
2023-06-20 4:30 pm Purchase | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | VIKING GLOBAL INVESTORS LP | 6,524,565 7.98% | 6,524,565 (New Position) | View |
2023-06-16 4:17 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 3,000,000 7.2% | 0 (Unchanged) | View |
2023-06-05 5:00 pm Purchase | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 1,320,656 7.9% | 1,320,656 (New Position) | View |